International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.13373685
Original Research Article
Thyroid Screening in Neonates in a Tertiary Care Center
Published
Nov. 28, 2024
Abstract

Background: Maternal thyroid disorders during pregnancy can significantly impact fetal development and increase the risk of adverse pregnancy outcomes, including miscarriage, preterm birth, low birth weight, and neonatal morbidity and mortality. This study aims to evaluate the prevalence of thyroid dysfunction in a cohort of 300 neonates (aged 1-28 days) at a tertiary care centre, with a focus on comparing the thyroid hormone levels between neonates born to mothers with and without thyroid disorders. Methods: This was a prospective, observational study conducted over a 12- month period. The neonates were further divided into two groups based on maternal thyroid status: (i) cases (N=150) and (ii) controls (n=150). In the first and third postnatal weeks, the study group's infants' thyroid tests were measured. Results: The mean TSH levels were significantly higher in neonates of mothers with thyroid disorders, while the mean free T4 level was significantly lower in this group. The prevalence of subclinical hypothyroidism (elevated TSH with normal free T4) was significantly higher. Conclusions: Early identification and management of thyroid disorders in newborns can help prevent the adverse effects on growth and neurodevelopment.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2619 Views
207 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved